Medable Partners with Google Cloud for Enhanced Clinical Trials
Medable and Google Cloud Create Synergy for Clinical Trials
Medable Inc., a top provider of clinical development technology, is thrilled to announce a new partnership with Google Cloud. This collaboration aims to introduce Medable’s Digital and Decentralized Clinical Trial Platform to the Google Cloud Marketplace. By leveraging Google Cloud’s powerful infrastructure and AI capabilities, customers will enjoy seamless integration with Medable’s advanced platform, which is particularly noted for its new SaaS solution, Studio. This initiative will support pharmaceutical companies in achieving greater control and transparency in the processes of clinical trial design, deployment, and management.
Enhanced Accessibility through Google Cloud Marketplace
The Google Cloud Marketplace is renowned for offering integrated solutions that meet the enterprise IT needs of its customers. Enterprises actively seek out Google Cloud Marketplace for third-party tools that allow them to build on and effectively use Google Cloud services. Through the ease of access provided by the marketplace, customers purchasing Medable solutions will enjoy consolidated billing. This means that usage of Medable services will appear straightforwardly on Google Cloud invoices, streamlining the billing process significantly.
Transforming Clinical Development with AI
The partnership stands to benefit clinical trial sponsors greatly. By harnessing the power of AI and advanced cloud technologies, clinical trial design, execution, and data management can be accelerated. Now, customers can take full advantage of Medable’s latest innovations across their enterprise and hybrid cloud environments, ensuring optimal efficiency and effectiveness in clinical trials.
Leaders in Clinical Technology Collaboration
Dr. Michelle Longmire, co-founder and CEO of Medable, highlighted the significance of this collaboration. She stated, "This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace. This collaboration will foster the broad adoption of Medable solutions among Google Cloud users, paving the way for improved patient access to clinical trials and accelerating imperative development efforts on a global scale." Such sentiments reflect a strong commitment to enhancing the clinical landscape through innovative technology solutions.
Impressive Achievements by Medable
Medable’s reputation continues to grow, especially as it ranks in the top 8% of software companies on the recent Inc. 5000 list. The company has successfully implemented its platform in over 300 decentralized and hybrid clinical trials across 60 countries, thereby serving more than a million patients and research participants worldwide. Noteworthy results include achieving 200 percent faster enrollment rates and cost reductions up to 50 percent. Research from Tufts CSDD has shown that decentralized clinical trials can yield considerable financial benefits, often providing a return on investment significantly exceeding initial costs.
Future Events and Learning Opportunities
Industry professionals can gain further insights into the advantages of Medable’s collaboration with Google Cloud at the upcoming Cancer AI Symposium. Scheduled for a soon-approaching date, this event will feature Dr. Michelle Longmire as a speaker, providing an excellent opportunity for attendees to learn about the cutting-edge innovations in clinical trials.
The Mission of Medable
At its core, Medable remains devoted to accelerating the delivery of effective therapies to patients. Its digital clinical trials platform is designed to enhance speed, scalability, and patient access, ultimately aiming to address myriad medical conditions still in search of treatment or cure. Recognized as the Best Digital Health Solution by the Galien Foundation, Medable’s platform has facilitated nearly 400 trials in 70 countries across 120 languages, positively impacting over a million patients globally. As a privately-held and venture-backed enterprise, the company continues to thrive, reflecting its commitment to transforming clinical development for improved patient outcomes.
Frequently Asked Questions
What is the purpose of Medable's partnership with Google Cloud?
The partnership aims to bring innovative clinical trial technology to the Google Cloud Marketplace, enhancing overall efficiency and accessibility for clients.
How does the Google Cloud Marketplace benefit Medable's customers?
Customers can easily access consolidated billing and streamlined procurement for Medable services, simplifying financial management.
What are some key achievements of Medable?
Medable has led over 300 decentralized trials, achieving rapid enrollment and significant cost savings, impacting over one million patients worldwide.
Will there be events related to Medable's collaboration with Google Cloud?
Yes, Medable will participate in the Cancer AI Symposium where insights on the collaboration will be shared.
What is Medable's mission?
Medable is dedicated to accelerating the availability of effective therapies by improving clinical trial speed, scale, and patient access.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.